Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
2013 ◽
Vol 76
(1)
◽
pp. 89-98
◽
Keyword(s):
2007 ◽
Vol 45
(06)
◽
pp. 335-344
◽
2015 ◽
Vol 5
(1)
◽
pp. 13-26
◽
Keyword(s):
2013 ◽
Vol 53
(3)
◽
pp. 249-255
◽
Keyword(s):
2008 ◽
Vol 47
(3)
◽
pp. 203-216
◽
2013 ◽
Vol 62
(2)
◽
pp. 212-221
◽
2009 ◽
Vol 68
(1)
◽
pp. 77-88
◽
2014 ◽
Vol 9
(1)
◽
pp. 75-83
◽
2012 ◽
Vol 40
(12)
◽
pp. 2250-2255
◽
2011 ◽
Vol 57
(2)
◽
pp. 201-206
◽
2016 ◽
Vol 9
(12)
◽
pp. 1111-1117
◽